Click on the subcategory below to find drug monographs for that particular area.
Individuals with a history of nonmelanoma skin cancer (NMSC) have an increased risk of subsequent primary cancers.
Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.
Pancreatic stellate cells, which normally aid tissue repair, unwittingly help pancreatic cancer grow and spread in a method of cell hijack only seen before in brain and breast cancer, according to new research. The research also revealed that the process can be blocked, thereby preventing the growth and spread of the tumor.
Teva Pharmaceutical announced the launch of Capecitabine Tablets, the generic equivalent to Genentech's Xeloda.
Terminally ill patients with cancer who receive chemotherapy at the end of life are at increased risk of dying in an ICU and receiving CPR and/or mechanical ventilation.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...
Nurse awareness of this treatment option and the patient selection criteria may be a significant ...